Sentiment Trading

Biotricity Inc., a healthcare technology company, has reported its first positive EBITDA and achieved significant revenue growth, positioning it for sustained growth in the wearable medical devices market.

Biotricity Inc. is set to release its fiscal 2026 first quarter financial results on August 14, 2025, providing insight into the company’s revenue growth, profitability, and operational efficiency.

Biotricity Inc. reports a 14.3% revenue increase to $13.8 million in fiscal year 2025, driven by strong demand for its remote monitoring solutions and operational efficiency improvements.